Revealing a Donor-Derived Microbiome Product for Infectious Disease Beyond the Gut
Time: 9:30 am
day: Focus Day
Details:
- Developing a donor-derived, cGMP manufactured oral capsule according to regulatory compliance.
- Outlining MVT-201: a microbiome-derived therapeutic product to eradicate MDR-bacteria from the reservoir, beyond gut infections.
- Exploring safety and efficacy of MVT-201 in infectious diseases murine modes
